A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential

@article{White2019ARO,
  title={A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential},
  author={C. White},
  journal={The Journal of Clinical Pharmacology},
  year={2019},
  volume={59}
}
  • C. White
  • Published 2019
  • Medicine
  • The Journal of Clinical Pharmacology
  • Cannabidiol (CBD) is a highly touted product for many different disorders among the lay press. Numerous CBD products are available, ranging from a US Food and Drug Administration (FDA)‐approved product called Epidiolex to products created for medical marijuana dispensaries and products sold in smoke shops, convenience stores, and over the Internet. The legal status of the non–FDA‐approved products differs depending on the source of the CBD and the state, while the consistency and quality of the… CONTINUE READING
    50 Citations

    Paper Mentions

    Interventional Clinical Trial
    The overarching objective of the proposed project is to test the clinical efficacy of CBD in the treatment of post-traumatic stress disorder using a rigorous double-blind randomized… Expand
    ConditionsPost Traumatic Stress Disorder
    InterventionDrug, Other
    Interventional Clinical Trial
    The overarching objective of the proposed project is to test the relative clinical efficacy of CBD isolate, full-spectrum CBD oil, and placebo in in reducing COVID-Induced stress… Expand
    ConditionsAlcohol Abuse, Anger, Anxiety Depression, (+3 more)
    InterventionDietary Supplement
    Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
    • 33
    The good face of Cannabis sativa: Cannabidiol
    • PDF

    References

    SHOWING 1-10 OF 65 REFERENCES
    The Trouble with CBD Oil
    • A. Hazekamp
    • Business
    • Medical Cannabis and Cannabinoids
    • 2018
    • 36
    Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
    • E. Perucca
    • Medicine
    • Journal of epilepsy research
    • 2017
    • 99
    • PDF
    Cannabidiol: State of the art and new challenges for therapeutic applications.
    • 179
    • PDF